1. Home
  2. BHM vs CCEL Comparison

BHM vs CCEL Comparison

Compare BHM & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bluerock Homes Trust Inc.

BHM

Bluerock Homes Trust Inc.

N/A

Current Price

$8.05

Market Cap

35.5M

Sector

Real Estate

ML Signal

N/A

Logo Cryo-Cell International Inc.

CCEL

Cryo-Cell International Inc.

SELL

Current Price

$4.42

Market Cap

32.7M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
BHM
CCEL
Founded
2022
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Managed Health Care
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
35.5M
32.7M
IPO Year
2022
2022

Fundamental Metrics

Financial Performance
Metric
BHM
CCEL
Price
$8.05
$4.42
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
2.0K
★ 10.5K
Earning Date
01-01-0001
10-09-2026
Dividend Yield
★ 6.27%
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ 0.23
Revenue
★ $68,734,000.00
$25,384,279.00
Revenue This Year
$1.31
N/A
Revenue Next Year
$11.18
N/A
P/E Ratio
★ N/A
$15.87
Revenue Growth
★ 36.88
9.76
52 Week Low
$7.87
$2.72
52 Week High
$13.30
$4.90

Technical Indicators

Market Signals
Indicator
BHM
CCEL
Relative Strength Index (RSI) 46.53 51.91
Support Level N/A $3.15
Resistance Level $8.87 $4.71
Average True Range (ATR) 0.33 0.38
MACD 0.01 -0.01
Stochastic Oscillator 22.50 53.06

Price Performance

Historical Comparison
BHM
CCEL

About BHM Bluerock Homes Trust Inc.

Bluerock Homes Trust Inc owns and operates a portfolio of institutional residential properties including single-family homes, build-to-rent communities, and other residential communities located in attractive markets with a focus on the knowledge-economy and high-quality of life growth markets of the Sunbelt and Western United States. The company's principal objective is to generate attractive risk-adjusted returns on investments where it believes it can drive growth in funds from operations and net asset value by acquiring residential units, developing residential communities, and through value-add renovations. The company has two reportable segments, consisting of Residential Communities, which derives maximum revenue; and Scattered Single-family homes.

About CCEL Cryo-Cell International Inc.

Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.

Share on Social Networks: